![\"\"](\"https:\/\/credevo.com\/articles\/\/wp-content\/uploads\/2019\/01\/Clinical_trial_regulatory_Newzealand_credevo.com_-300x161.jpg\")
<\/figure><\/div>\n\n\nNew Zealand, a country named the third most beautiful country in the world with stunning and diverse natural beauty, and jagged mountains, is full of islands with one of Earth’s most peculiar bioregions, inhabited by flightless birds seen nowhere else such as a nocturnal, burrowing parrot and kiwi. Now, New Zealand is also known as the preferred\u00a0country for conducting Clinical Trials.<\/p>\n\n\n\n
Why Clinical Trials in New Zealand?<\/h2>\n\n\n\n
Here are the top 5 reasons to conduct clinical trials in New Zealand:<\/p>\n\n\n\n
- \n
- Streamlined Regulatory Process<\/strong>: Faster and more flexible approvals through Medsafe and ethics committees, enabling quicker trial initiation.<\/li>\n\n\n\n
- Cost-Effective<\/strong>: Lower overhead and healthcare costs make it a financially attractive option compared to larger markets.<\/li>\n\n\n\n
- High-Quality Research Infrastructure<\/strong>: World-class hospitals and research centers, produce internationally accepted data.<\/li>\n\n\n\n
- Diverse Patient Population<\/strong>: A varied ethnic demographic provides valuable insights for studying treatment effects across different groups.<\/li>\n\n\n\n
- Skilled Professionals<\/strong>: A highly trained workforce ensures trials are conducted efficiently and meet global standards.<\/li>\n<\/ol>\n\n\n\n
New Zealand<\/strong> has a great track record of early phase and proof of concept trials validated by independent, clean, and accurate clinical data.<\/p>\n\n\n\n
Regulatory Authority in New Zealand<\/h2>\n\n\n\n
- \n
- The Director-General of Health <\/strong>requires approval before commencing a clinical trial using a new medicine in New Zealand.<\/li>\n\n\n\n
- Health Research Council (HRC)<\/strong> – The Health Research Council (HRC)<\/a> of New Zealand makes a recommendation to the Director-General on the clinical trial application.<\/li>\n\n\n\n
- Medsafe<\/strong> – The application and approval process for clinical trials is administered by Medsafe<\/a>.<\/li>\n\n\n\n
- Health and Disability Ethics Committees<\/strong> – The Health and Disability Ethics Committees (HDECs)<\/a> administer the ethics approval system, which applies to all clinical trials conducted in New Zealand.<\/li>\n<\/ul>\n\n\n\n
\n\n\n\n\n
Curious to understand the clinical trial approval process in Australia? Click here for insights.<\/a><\/p>\n<\/blockquote>\n\n\n\n
\n\n\n\nHealth Research Council of New Zealand (HRC)<\/h2>\n\n\n\n
- \n
- The <\/strong>Health Research Council of New Zealand (HRC) recommends the approval of clinical trials to the Director – General Health<\/strong><\/li>\n\n\n\n
- The HRC maintains two standing committees to consider clinical trial applications and make recommendations to the Director-General.<\/li>\n\n\n\n
- Standing Committee on Therapeutic Trials (SCOTT)<\/strong> considers applications for new pharmaceutical-type medicines, and the Gene Technology Advisory Committee (GTAC).<\/strong><\/li>\n<\/ul>\n\n\n\n
What is Medsafe?<\/h2>\n\n\n\n
- \n
- Medicines and Medical Devices Regulatory Authority for New Zealand is Medsafe.<\/li>\n\n\n\n
- It administers the regulatory application for clinical trials under Section 30 of the Medicines Act 1981, involving the use of new medicines, unregistered medicines, scientific assessment of gene technology, and medical devices. Medsafe issues approvals under a delegation from the Director-General of Health.<\/li>\n\n\n\n
- Medsafe receives and processes applications, liaises with the relevant Health Research Council committee (Standing Committee On Therapeutic Trials (SCOTT) or Gene Technology Advisory Committee (GTAC) and the applicant, and issues approval letters.<\/li>\n\n\n\n
- It also administers a notification scheme for clinical trial sites that have patients in residence and maintains a list of sites for which it has received notification of compliance with Good Clinical Practice requirements.<\/li>\n<\/ul>\n\n\n\n
Health and Disability Ethics Committee (HDEC)<\/h2>\n\n\n\n
New Zealand has two types of approved Ethics Committee (EC) that conduct ethical reviews of clinical trials<\/p>\n\n\n\n
- \n
- Most clinical trial approvals use HDECs, and <\/li>\n\n\n\n
- Institutional Ethics Committees (IEC) handle late-phase research involving humans originating from that specific institution.<\/li>\n<\/ul>\n\n\n\n
The New Zealand Health and Disability Ethics Committee (HDEC)<\/strong> administers the ethics approval system, which applies to interventional clinical trials regardless of whether they are trials that require approval under Section 30 of the Medicines Act.<\/p>\n\n\n\n
Clinical Trial Sites in New Zealand<\/h2>\n\n\n\n
The application must include information about the site(s) at which the trial is to be conducted, and the facilities available at those sites. This information is also taken into consideration in deciding to approve the trial.<\/p>\n\n\n\n
The person who manages the site (where study participants stay overnight) completes a Clinical Trial Site Notification form and should notify that the site has adequate emergency procedures in place.<\/p>\n\n\n\n
On receipt of a completed notification, Medsafe will add the site to a list of Notified Clinical Trial Sites on the Medsafe website (http:\/\/www.medsafe.govt.nz\/regulatory\/CSSites.htm<\/a>).<\/p>\n\n\n\n
Clinical Trial Registry in New Zealand<\/h2>\n\n\n\n
- Health Research Council (HRC)<\/strong> – The Health Research Council (HRC)<\/a> of New Zealand makes a recommendation to the Director-General on the clinical trial application.<\/li>\n\n\n\n
- Cost-Effective<\/strong>: Lower overhead and healthcare costs make it a financially attractive option compared to larger markets.<\/li>\n\n\n\n
![\"Clinical](\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2024\/10\/Clinical_trial_approval_process_flow_New_Zealand_Medsafe_Credevo.png\")
<\/figure><\/div>\n\n\n